Skip to content

Coagulation Parameters During Pregnancy in Amniotic Fluid

Coagulation Parameters During Pregnancy in Amniotic Fluid

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00458666
Enrollment
170
Registered
2007-04-11
Start date
2006-06-30
Completion date
Unknown
Last updated
2007-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy

Keywords

Amniotic fluid, D-dimer, coagulation, factor X activation

Brief summary

Amniotic fluid embolism is a rare devastating thromboembolic event, which is probably caused by the entrance of amniotic fluid (AF) to the maternal circulation. While AF contains coagulation activators, their role during pregnancy has not been elucidated. The current study aimed to evaluate coagulation parameters in AF during human pregnancy.

Detailed description

Amniotic fluid embolism is a rare devastating thromboembolic event, which is probably caused by the entrance of amniotic fluid (AF) to the maternal circulation. While AF contains coagulation activators, their role during pregnancy has not been elucidated. The current study aimed to evaluate coagulation parameters in AF during human pregnancy.

Interventions

None listed

Sponsors

Rambam Health Care Campus
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Women undergoing amniocentesis during 15-35 weeks of gestation.

Exclusion criteria

* A history of venous thromboembolism * Systemic disease i.e.; diabetes, hypertension, hypo or hyper-thyroidism, * Anticoagulant treatment * Abnormal embryo

Countries

Israel

Contacts

Primary ContactGalit Sarig, Ph.D
g_sarig@rambam.health.gov.il+972-50-2061462

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026